Vestcor Inc Eli Lilly & CO Transaction History

Vestcor Inc

$3.17 Billion
Q3 2024

A detailed history of Vestcor Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Vestcor Inc holds 47,371 shares of LLY stock, worth $36.9 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares

47,371

Previous 48,687 2.7%

Holding current value

$36.9 Million

Previous $44.1 Million 4.79%

% of portfolio

1.32%

Previous 1.49%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$772.14 - $960.02 $1.02 Million - $1.26 Million	-1,316 Reduced 2.7%	47,371 $42 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $17 Million - $21.4 Million	-23,489 Reduced 32.54%	48,687 $44.1 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $5.83 Million - $7.81 Million	-9,852 Reduced 12.01%	72,176 $56.2 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $1.65 Million - $1.94 Million	-3,139 Reduced 3.69%	82,028 $47.8 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $2.13 Million - $2.93 Million	-4,896 Reduced 5.44%	85,167 $45.7 Million
Q2 2023 Aug 15, 2023	SELL	$350.74 - $468.98 $3.61 Million - $4.83 Million	-10,300 Reduced 10.26%	90,063 $42.2 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $6.69 Million - $7.86 Million	21,538 Added 27.32%	100,363 $34.5 Million
Q4 2022 Feb 15, 2023	SELL	$321.55 - $374.67 $1.39 Million - $1.62 Million	-4,312 Reduced 5.19%	78,825 $28.8 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $139,049 - $158,461	-469 Reduced 0.56%	83,137 $26.9 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $1.42 Million - $1.67 Million	5,097 Added 6.49%	83,606 $27.1 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $2.57 Million - $3.2 Million	-10,960 Reduced 12.25%	78,509 $22.5 Million
Q4 2021 Feb 15, 2022	SELL	$224.85 - $279.04 $1.22 Million - $1.52 Million	-5,437 Reduced 5.73%	89,469 $24.7 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $350,128 - $430,881	-1,580 Reduced 1.64%	94,906 $21.9 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $357,127 - $461,942	1,978 Added 2.09%	96,486 $22.1 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $71,807 - $92,958	-437 Reduced 0.46%	94,508 $17.7 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $173,903 - $230,115	-1,333 Reduced 1.38%	94,945 $16 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $222,108 - $256,908	-1,519 Reduced 1.55%	96,278 $14.3 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $582,240 - $700,720	4,268 Added 4.56%	97,797 $16.1 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $868,945 - $1.08 Million	7,299 Added 8.46%	93,529 $13 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $9.22 Million - $11.4 Million	86,230 New	86,230 $11.3 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.

Account